[American Chemical Society](https://www.acs.org)

Program closed (last cycle: September 1, 2021–August 31, 2023)

$100,000/year for 3 years (total $300,000); 1 award per cycle

Supported innovative research in organic and medicinal chemistry by recently tenured US faculty, fostering advances relevant to human medicines.

Program is no longer accepting new applications.

--- ## Description The Teva Pharmaceuticals Marc A. Goshko Memorial Grant, administered by the American Chemical Society (ACS) and funded by Teva Pharmaceuticals, recognized and supported innovative academic research in organic and medicinal chemistry from 2009 to 2023. The grant aimed to foster projects with significant potential for practical impact in the discovery of organic compounds beneficial as human medicines. Emphasis was placed on scientific merit, creativity, novelty, and addressing unexplored areas within the field. Awardees were required to submit annual reports and present a lecture upon completing the grant. --- ## Due Dates - The program is closed and not accepting new applications. - Last known award period: September 1, 2021 – August 31, 2023. --- ## Funding Amount - $100,000 per year for 3 years (total $300,000 per award) - Only one award was made per cycle. - No institutional overhead or administrative charges allowed. - Up to $10,000/year for PI salary; up to $5,000/year for travel. --- ## Eligibility - Applicants had to be recently tenured faculty members at Ph.D.-granting departments in the United States. - First tenure decision must have occurred during or after the 2012–2013 academic year. - Research had to be in organic chemistry with direct or potential application to medicinal or pharmaceutical chemistry, aiming for practical benefits in human medicine discovery. --- ## Application Process - The program is no longer accepting new applications. - When active, applicants submitted a detailed proposal including budget, research narrative, and supporting documents. - Required institutional endorsement and compliance with ACS’s scientific misconduct policy. - Annual financial and scientific progress reports were mandatory. - Recipients were required to present a lecture following the grant period. --- ## Additional Information - No institutional overhead or facilities/administrative charges permitted. - Budget flexibility allowed with prior ACS approval; unspent funds could roll over to subsequent years within the same category. - Support for personnel (students, postdocs, technicians) and research expenses was permitted as per ACS guidelines. --- ## External Links - [Program Overview and Past Recipients](https://www.acs.org/content/acs/en/funding/grants/teva-pharmaceuticals-marc-goshko-memorial-grant.html) - [Eligibility, Terms & Conditions (PDF)](https://www.acs.org/content/dam/acsorg/funding/grants/teva-pharmaceuticals-scholars-grants/teva_etc_2018_v2.pdf) --- ## Contact Information | Name | Role | Email | Phone | |------------------|------------------|-------------------------------|-----------------| | Dr. Nancy Jensen | Program Manager | n_jensen@acs.org | 202-872-6186 | | ACS General | Help/Support | help@services.acs.org | +1 800-227-5558 | ---

Teva Pharmaceuticals Marc A. Goshko Memorial Grant

Sign in to see full grant listing